HHealthcare Read More J&J falls despite a beat-and-raise quarter. Why we’re raising our price target anywaysJuly 21, 2026 Johnson & Johnson shares fell Tuesday despite a mostly strong second-quarter earnings report and an increase to its…
HHealthcare Read More Johnson & Johnson has a chance to show it’s more than just a rotation winnerJuly 14, 2026 Johnson & Johnson shares have showed signs of life ahead of earnings. For the stock to keep running,…